Karen Lane
Johns Hopkins University
H-index: 25
North America-United States
Top articles of Karen Lane
Clinical Trial Protocol for BEACH: A Phase 2a Study of MW189 in Patients with Acute Nontraumatic Intracerebral Hemorrhage
Neurocritical care
2024/4
W Andrew Mould
H-Index: 11
Karen Lane
H-Index: 17
Erratum for Gebo et al.,“Early antibody treatment, inflammation, and risk of post-COVID conditions”
Mbio
2024/1/16
Trial readiness of cavernous malformations with symptomatic hemorrhage, part I: event rates and clinical outcome
Stroke
2024/1
Mechanisms to expedite pediatric clinical trial site activation: The DOSE trial experience
Contemporary Clinical Trials
2023/2/1
Transfusing convalescent plasma as post-exposure prophylaxis against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a double-blinded, phase 2 …
Clinical infectious diseases
2023/2/1
Shmuel Shoham
H-Index: 29
Arturo Casadevall
H-Index: 80
Daniel Hanley
H-Index: 17
Bryan Lau
H-Index: 9
Kelly Gebo
H-Index: 46
Adam C Levine
H-Index: 22
Arash Naeim
H-Index: 20
Lawrence Appel
H-Index: 99
Anthony Bowen
H-Index: 9
Stephan Ehrhardt
H-Index: 22
Donald Forthal
H-Index: 30
Sabra Klein
H-Index: 44
Karen Lane
H-Index: 17
Andrew Pekosz
H-Index: 32
Development, implementation, and dissemination of operational innovations across the trial innovation network
Journal of Clinical and Translational Science
2023/1
Decentralized clinical trials in the trial innovation network: Value, strategies, and lessons learned
Journal of Clinical and Translational Science
2023/1
Cavernous Angioma Symptomatic Hemorrhage (CASH) Trial Readiness II: Imaging Biomarkers and Trial Modeling
medRxiv
2023
401. Risk of Post-COVID Conditions Correlates with IL-6 Plasma Levels and Is Reduced by Early Antibody Therapy
Open Forum Infectious Diseases
2023/12
Approaches for enhancing the informativeness and quality of clinical trials: Innovations and principles for implementing multicenter trials from the Trial Innovation Network
Journal of clinical and translational science
2023/1
Early antibody treatment, inflammation, and risk of post-COVID conditions
Mbio
2023/10/31
Early Treatment, Inflammation and Post-COVID Conditions (preprint)
Mbio
2023/10/31
Leveraging the Expertise of the CTSA Program to Increase the Impact and Efficiency of Clinical Trials
JAMA network open
2023/10/2
Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort study
The Lancet Microbe
2023/9/1
Transfusion reactions associated with COVID‐19 convalescent plasma in outpatient clinical trials
Transfusion
2023/9
Antibody Correlates of Protection for COVID-19 Convalescent Plasma Associated with Reduced Outpatient Hospitalizations.
Medrxiv: the Preprint Server for Health Sciences
2023/4/24
Convalescent plasma with a high level of virus-specific antibody effectively neutralizes SARS-CoV-2 variants of concern
Blood advances
2022/6/28
How do I implement an outpatient program for the administration of convalescent plasma for COVID‐19?
Transfusion
2022/5
High viral specific antibody convalescent plasma effectively neutralizes SARS-CoV-2 variants of concern
medRxiv
2022/3/2
Using gamification to enhance clinical trial start-up activities
Journal of Clinical and Translational Science
2022/1